We tested the hypothesis that the excitatory neurotransmitter receptor agon
ist, alpha amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), would wo
rsen cerebral cortical oxygen supply/consumption balance during focal ische
mia. In this study, we compared regional cerebral blood flow, arterial and
venous O-2 saturation, O-2 extraction and oxygen consumption of ischemic an
d AMPA treated ischemic and control regions of rat brain. Ischemia was indu
ced by middle cerebral artery (MCA) occlusion in isoflurane (1.4%) anesthet
ized Wistar rats. Twenty minutes after MCA occlusion, 10(-5) M AMPA was app
lied to the ischemic cortex (IC) for a period of 40 min; the fluid was chan
ged every 10 min. After I hr of ischemia, animals were sacrificed and regio
nal cerebral blood flow (rCBF) was determined using the C-14-iodoantipyrine
autoradiographic technique. Regional arterial and venous oxygen saturation
were determined microspectrophotometrically. In control, the cerebral bloo
d flow and oxygen consumption of the IC were significantly lower than the c
ontralateral cortex (rCBF: 46 +/- 20 vs. 81 +/- 39 ml/min/100g, O-2 consump
tion: 2.8 +/- 1.4 vs. 3.6 +/- 1.4 mi O-2/min/100g). 10(-5) M AMPA did not s
ignificantly alter regional cerebral blood flow and oxygen consumption of t
he IC, but did decrease the average venous O-2 saturation of the IC from 50
.2 +/- 3.9% to 46.7 +/- 1.6%. AMPA also significantly increased the frequen
cy of small veins with less than 45% O-2 saturation in the IC (8 out of 56
veins in IC vs. 18 out of 56 veins in AMPA treated IC). Thus, topical appli
cation of 10-5 M AMPA to the ischemic area worsens cerebral O-2 balance and
suggests that excitatory amino acids contribute to the degree of cerebral
ischemia.